natgillin/translations-raw huggingface dataset:
Conditions which may make the early warning symptoms of hypoglycaemia different or less pronounced include long duration of diabetes, intensified insulin therapy, diabetic nerve disease or medicinal products such as beta-blockers.
Stanja, pri katerih so zgodnji opozorilni znaki hipoglikemije drugačni ali manj izraziti, so dolgotrajni diabetes, intenzivirana insulinska terapija, diabetična nevropatija ali zdravila, kot so beta blokatorji.
Conditions with decreased gastro-intestinal transit time
Stanja s skrajšanim časom prehoda skozi prebavila
Conditions with increased potential for gastrointestinal perforation
Bolezni in motnje, povezane z večjo možnostjo za perforacijo prebavil
Conditions you may need to look out for
Stanja, na katera morate biti pozorni
Conditions you need to look out for include the following Liver Problems
Stanja, na katera morate biti pozorni, so naslednja Težave z jetri
conditions*
aplikacije
Condom use applies for both reproductively competent and vasectomized men, because the risks associated with the transfer of seminal fluid also apply to men who have had a vasectomy.
Uporaba kondoma se nanaša na moške, zmožne reprodukcije in tiste, ki so imeli vazektomijo, ker tveganja, povezana s prenosom semenske tekočine, obstajajo tudi pri moških, ki so imeli vazektomijo.
Condom use applies for both reproductively competent and vasectomized men, because the risks associated with the transfer of seminal fluid also apply to men who have had a vasectomy.
Uporaba kondoma se nanaša na moške, zmožne reprodukcije, in tiste, ki so imeli vazektomijo, ker tveganja, povezana s prenosom semenske tekočine, obstajajo tudi pri moških, ki so imeli vazektomijo.
conduct a surveillance programme/ registry according to an agreed protocol and for an
protokolom in za nedoločen čas izvajati program za nadzor/register.
Conduct non-clinical (including mechanistic) studies in order to elucidate the role of the vaccine and its adjuvant on the association between Pandemrix and narcolepsy:
Izvedba nekliničnih študij (vključno s študijami mehanizma) za razjasnitev vloge cepiva in njegovega adjuvansa pri povezavi med cepivom Pandemrix in narkolepsijo.
Conduct of a prospective cohort study assessing the incidence of cardiovascular adverse events in patients starting GILENYA treatment for relapsing remitting multiple sclerosis based on a CHMP approved protocol.
izvesti prospektivno kohortno študijo za oceno pogostnosti kardiovaskularnih neželenih dogodkov pri bolnikih, ki začenjajo zdravljenje z zdravilom GILENYA zaradi recidivno-remitentne multiple skleroze po protokolu, ki ga je odobril odbor CHMP.
Conduct of all procedures required for the correct management and maintenance of the Medtronic MiniMed Implantable Pump and the PPC, including rinsing procedures and instructions as to how to handle messages, alarms and routine warnings issued by the PPC;
Izvedbi vseh postopkov, potrebnih za pravilno upravljanje in vzdrževanje črpalke Medtronic MiniMed Implantable Pump in PPC, vključno s postopki za izpiranje in navodili za ravnanje v odziv na sporočila, alarme in rutinska opozorila, ki jih da PPC.
Conducted RF
Prevajana RF
conducted with the objective to further characterise the adverse drug reaction
promet z zdravilom (PASS) z namenom nadaljnje opredelitve profila o neželenih
Conduction disorder
motnja prevajanja
Conestat alfa is produced by ‘recombinant DNA technology’: it is extracted from the milk of rabbits that have been given genes that make them able to produce the human protein in their milk.
Konestat alfa se proizvaja s „tehnologijo rekombinantne DNK“: pridobljen je iz mleka kuncev, ki so prejeli gene, s katerimi lahko v svojem mleku tvorijo človeško beljakovino.
Conestat alfa, recombinant human complement component 1 (C1) esterase inhibitor (rhC1INH), is an analogue of human C1INH and is obtained from the milk of rabbits expressing the gene encoding for human C1INH.
Konestat alfa, rekombinantna humana sestavina komplementa 1 (C1) zaviralca esteraze (rhC1INH), je analog humanega C1INH in se ga pridobiva iz mleka kuncev, ki izražajo kodiranje gena za humani C1INH.
Confidence Interval
interval zaupanja
Confidence interval (95%)
Interval zaupanja (95 %)
Confirm dose delivery
Prepričajte se, da je bil odmerek injiciran
Confirm elevation with a repeat measurement within one week.
Potrdite povišanje s ponovno meritvijo v roku enega tedna.
Confirm insertion of the implant by palpating the skin with subcutis cranial to/overlying the suprailiac crest until the implant is located.
Vsaditev implantata potrdite s palpacijo kože, ki je nad/prekriva suprailiakalno kristo, dokler ne ugotovite mesta implantata.
Confirm the dose and concentration in the syringe prior to use (check that the syringe is marked as intravenous administration).
Pred dajanjem zdravila preverite odmerek in koncentracijo v brizgi (prepričajte se, da je na brizgi oznaka za intravensko dajanje).
Confirm the dose and concentration in the syringe prior to use. (check that the syringe is marked as subcutaneous administration).
Pred dajanjem zdravila preverite odmerek in koncentracijo v brizgi (prepričajte se, da je na brizgi oznaka za intravensko dajanje).
Confirm the dose and concentration in the syringe prior to use. (check that the syringe is marked as subcutaneous administration).
Pred dajanjem zdravila preverite odmerek in koncentracijo v brizgi (prepričajte se, da je na brizgi oznaka za subkutano dajanje).
Confirm the dose and concentration in the syringe prior to use. (Check that the syringe is marked as subcutaneous administration.)
Pred dajanjem zdravila preverite odmerek in koncentracijo v brizgi (prepričajte se, da je na brizgi oznaka za intravensko dajanje).
Confirm the joint to be treated (metacarpophalangeal [MP] or proximal interphalangeal [PIP]) as the volume of solvent required for reconstitution is determined by the type of joint (PIP joint requires a smaller volume for injection).
Preverite, kateri sklep boste zdravili (metakarpofalagealni [MP] ali proksimalni interfalagealni [PIP]), saj je volumen vehikla, ki je potreben za rekonstitucijo, določen glede na vrsto sklepa (za PIP sklep je potreben manjši volumen za injiciranje).
Confirm you receive a complete injection (7) or record the number shown in the Dose Feedback Window if other than ‘’0’’ (8).
Potrdite, da ste prejeli celo injekcijo (7) ali zabeležite številko, prikazano v oknu za prikaz odmerka, če ni "0" (8).
Confirmation on appropriate settings (emergency resuscitation equipment available ) prior to administration of ferumoxytol
potrditev ustreznih pogojev (razpoložljiva oprema za oživljanje v nujnem primeru) pred dajanjem ferumoksitola
Confirmation that the physician has discussed the following:
potrdilo, da se je zdravnik pogovoril o naslednjem:
Confirmatory clinical trials in adult treatment-naïve patients
Potrdilna klinična preskušanja pri odraslih bolnikih, ki se še niso zdravili
Confirmed 3
Potrjene3
Confirmed ALT or AST
Potrjena vrednost ALT ali AST
Confirmed ALT or AST > 3 x ULN and bilirubin > 2 x ULN
Potrjena vrednost ALT ali AST > 3-kratna ULN in bilirubina > 2-kratna ULN
Confirmed complete or partial overall response, n (%)
potrjen popoln ali delen celokupen odziv, n (%)
Confirmed HBeAg seroconversion occurred in 47 % (118/252) of subjects treated with lamivudine and 93 % (320/345) of subjects receiving lamivudine became HBV DNA negative (VERSANT [version 1], bDNA assay, LLOD < 0.7 MEq/ml) during the study.
Potrjena serokonverzija HBeAg se je pojavila pri 47 % (118/252) oseb, ki so se zdravile z lamivudinom, 93 % (320/345) oseb, ki so dobivale lamivudin, pa je med študijo postalo HBV DNA- negativnih (VERSANT [verzija 1], bDNA test, LLOD < 0,7 Meq/ml).
Confirmed HBeAg seroconversion occurred in 47 % (118/252) of subjects treated with lamivudine and 93 % (320/345) of subjects receiving lamivudine became HBV DNA negative (VERSANT [version 1], bDNA assay, LLOD < 0.7 MEq/ml) during the study.
Potrjena serokonverzija HBeAg se je pojavila pri 47 % (118/252) oseb, zdravljenih z lamivudinom, 93 % (320/345) oseb, ki so prejemale lamivudin, pa je med študijo postalo HBV DNA negativnih (VERSANT verzija 1, bDNA test, LLOD  0,7 Meq/ml).
Confirmed HCV ≥ 25 IU/mL after HCV RNA < 25 IU/mL during treatment, confirmed 1 log10 IU/mL increase in HCV RNA from nadir, or HCV RNA persistently ≥ 25 IU/mL with at least 6 weeks of treatment.
Potrjen HCV ≥ 25 i.e./ml po HCV RNA < 25 i.e./ml med zdravljenjem, potrjeno zvečanje HCV RNA za 1 log10 i.e./ml od najnižje točke, ali HCV RNA stalno ≥ 25 i.e./ml ob vsaj 6 tednih zdravljenja.
Confirmed hypoglycaemia was defined as episodes confirmed by plasma glucose < 3.1 mmol/L or by the patient needing third party assistance.
2 Potrjena hipoglikemija je bila opredeljena kot potrjena koncentracija glukoze v plazmi < 3,1 mmol/l ali potreba po pomoči druge osebe.
Confirmed hypoglycaemia was defined as episodes confirmed by plasma glucose < 3.1 mmol/L or by the patient needing third party assistance.
Potrjena hipoglikemija je bila opredeljena kot potrjena koncentracija glukoze v plazmi < 3,1 mmol/l ali potreba po pomoči druge osebe.
Confirmed hypoglycaemiaa
Izidi metaanalize hipoglikemij
confirmed in clinical
kliničnih študijah ni bilo
Confirmed increase in serum creatinine
potrjeno zvišanje serumske koncentracije kreatinina za
Confirmed objective response(IRRC)
Potrjeni objektivni odziv (IRRC)
Confirmed undetectable viral
Potrjeno nemerljivo virusno
Confirms that a stream of insulin comes out of the tip of the needle when you push the Dose Knob in.
Za zagotovitev, da bo ob pritisku na gumb za odmerjanje iz konice igle pritekel curek insulina.
conflicting effect of tipranavir, co-
Buprenorfin/nalokson
Conflicting findings are reported in literature on co-administration between abacavir and ribavirin.
V literarturi so prijavljene nasprotujoče si ugotovitve o sočasni uporabi abakavira in ribavirina.
Conforming to the individual dose, the tablet or the halves or quarters of the tablet should be taken once daily, preferably in the morning before breakfast and, where necessary, with a glass of water or a very small amount of food.
Skladno z individualnim odmerkom je treba vzeti eno tableto ali polovico ali četrtino tablete enkrat na dan, po možnosti zjutraj pred zajtrkom in, če je potrebno, s kozarcem vode ali z zelo majhno količino hrane.
Conforming to the individual dose, the tablet should be taken once daily, preferably in the morning before breakfastand, where necessary, with a glass of water or a very small amount of food.
Skladno z individualnim odmerkom je treba vzeti eno tableto enkrat na dan, po možnosti zjutraj pred zajtrkom in, če je potrebno, s kozarcem vode ali z zelo majhno količino hrane.
Conformity to the EMC directive 2004/108/EG
Skladnost z EMC direktivo (2004/108/EC) Tip baterije
Confusion
stanje zmedenosti
confusion
zmedenost,
Confusion
zmedenost;
confusion aggravated
poslabšanje zmedenosti
confusion and dis-
zmedenost in dezorientiranost,
Confusion or change in how alert you are,
zmedenost ali spremembo pozornosti,
Confusion or feeling disorientated
zmedenost ali občutek dezorientiranosti,
confusion,
zmedenost
confusion,
zmedenost,
Confusion, anxiety, depression, dizziness, difficulty sleeping (insomnia)
zmedenost, tesnobnost, potrtost, omotica, težave s spanjem (nespečnost),
Confusion, Delusions, Delirium, Hallucination, Nightmares,
prividi, delirij, halucinacije, nočne more, samopoškodba
confusion, depressed level of consciousness (e.g. coma).
poskušajte nadomestiti pozabljenega odmerka.
confusion, depressed level of consciousness (e.g. coma).
zmedenost, zmanjšana zavest (na primer koma).
confusion, depressed level of consciousness (e.g. coma).
zmedenost, zmanjšana zavest (npr. koma).
confusion, disorientation
zmedenost, dezorientiranost,
confusion, disorientation, memory loss, disturbed mood, lack of energy
zmedenost, dezorientacija, izguba spomina, motnje razpoloženja, pomanjkanje energije
confusion, feeling depressed; suicidal thoughts or aggressive behaviour, attempt suicide, thoughts about threatening the life of others
zmedenost, depresivnost; samomorilne misli ali agresivno obnašanje, poskus samomora; misli kako ogroziti življenja drugih;
confusion, feeling depressed; suicidal thoughts or aggressive behaviour, attempt suicide, thoughts about threatening the life of others
zmedenost, depresivnost; samomorilne misli ali agresivno vedenje, poskus samomora; misli kako ogroziti življenja drugih;
confusion, feeling depressed; suicidal thoughts or aggressive behaviour, attempt suicide, thoughts about threatening the life of others,
zmedenost, depresivnost, samomorilne misli ali agresivno obnašanje, poskus samomora, misli kako ogroziti življenje drugih
confusion, feeling depressed; suicidal thoughts or aggressive behaviour, attempt suicide, thoughts about threatening the life of others,
zmedenost, depresivnost; samomorilne misli ali agresivno obnašanje, poskus samomora, misli kako ogroziti življenja drugih,
Confusion, hallucination
diplopija
Confusion, memory loss or problems thinking
zmedenost, izgubo spomina ali težave pri mišljenju,
Confusion, sleep disorder, libido decreased
zmedenost, motnje spanja, zmanjšana spolna sla
confusion, tiredness, muscle twitching and spasm, rapid breathing (hypochloraemic alkalosis)
zmedenost, utrujenost, trzanje mišic in mišični krči, hitro dihanje (hipokloremična alkaloza)
Confusion, tiredness, muscle twitching and spasm, rapid breathing (hypochloraemic alkalosis)
zmedenost, utrujenost, trzanje mišic in mišični krči, hitro dihanje (hipokloremična alkaloza),
confusion, visual loss or disturbances, blindness, seizures, headaches
zmedenost, izguba ali motnje vida, slepota, epileptični napadi, glavoboli
Confusion.
zmedenost
Confusion.
Zmedenost.
confusion; inflammation of the veins and formation of blood clots in the veins which could lead to blockage of blood flow to your lungs causing difficulty breathing, chest pain and palpitations.
zmedenost vnetje ven in nastanek krvnih strdkov v venah, ki lahko zamašijo pretok krvi do pljuč in povzročijo težave z dihanjem, bolečino v prsih in razbijanje srca (palpitacije)
Confusional state
povečanje
Confusional state
stanje zmedenosti
Confusional state
tanje zmedenosti
confusional state
zmedenost
Confusional state Acute psychosis Aggression Suicidal ideation Hallucination
stanje zmedenosti akutna psihoza agresivnost samomorilne misli halucinacije
Confusional state Mental status changes
tanje zmedenosti duševne motnje
Confusional state Psychotic disorders Hallucinations Disorientation Anxiety
stanje zmedenosti, psihotične motnje, halucinacije, dezorientiranost, anksioznost
Confusional state*
tanje zmedenosti
confusional state, anxiety
tanje zmedenosti, tesnoba
Confusional state, Anxiety, Depression, Dizziness, Insomnia
stanje zmedenosti, anksioznost, depresija, omotica, nespečnost
Confusional state, depressed mood
stanje zmedenosti, depresivno razpoloženje
Confusional state, Panic attack, Depressed mood, Libido decreased
stanje zmedenosti, panični napad, depresivno razpoloženje, zmanjšan libido
confusional state, panic attacks, depressed mood, decreased libido
tanje zmedenosti, napadi panike, depresivno razpoloženje, zmanjšan libido,
confusional state, panic attacks, depressed mood, decreased libido
zmedeno stanje, napade panike, depresivno razpoloženje, zmanjšan libido,
confusional state, panic attacks, depressed mood, decreased libido
zmedenost, panični napadi, depresivno razpoloženje, zmanjšan libido
Confusional state, restlessness, personality disorder, hallucination, depression, anxiety, libido decreased, sexual inhibition
zmedenost, nemir, osebnostna motnja, halucinacije, depresija, tesnoba, zmanjšan libido, motnje spolne funkcije
Confusionam
zmedenostam
Congenital abnormalities (birth defects) have been reported in babies whose mothers took mercatopurine, particularly in combination with other cancer medicines.
Poročali so o prirojenih nepravilnostih (prirojene okvare) pri otrocih, katerih matere so jemale merkaptopurin, zlasti v kombinaciji z drugimi zdravili proti raku.
Congenital AIDS
Otroci in mladostniki z AIDS-om
Congenital AIDS and recurrent bacterial infections.
Kongenitalni AIDS in ponavljajoče se bakterijske okužbe.
Congenital AIDS with recurrent bacterial infections.
Kongenitalnem AIDS-u s ponavljajočimi se bakterijskimi okužbami.
Congenital AIDS with recurrent bacterial infections.
Kongenitalnemu AIDS-u s ponavljajočimi se bakterijskimi okužbami.
Congenital and familial and genetic disorders
Vrojene, dedne in genetske okvare
Congenital and familial/genetic disorders
Prirojene in dedne genetske okvare
Congenital anomalies
Prirojene okvare
congenital choroid plexus cyst;
kongenitalne ciste horoidnega pleksusa,
Congenital heart disease such as atrial and ventricular septal defects;
kongenitalna bolezen srca, kot sta atrijski in ventrikularni septum defekt,
Congenital long QTc syndrome.
Sindrom prirojenega podaljšanja QTc.
Congenital malformations have been observed post-marketing in children of patients exposed to CellCept in combination with other immunosuppressants, see section 4.6.
Po prihodu zdravila na trg so pri otrocih bolnikov, ki so bili izpostavljeni zdravilu CellCept v kombinaciji z drugimi imunosupresivi, poročali o kongenitalnih malformacijah; glejte poglavje 4.6.
Congenital malformations have been observed post-marketing in children of patients exposed to mycophenolate mofetil in combination with other immunosuppressants, see section 4.6.
Po prihodu zdravila na trg so pri otrocih bolnikov, ki so bili izpostavljeni zdravilu Myfenax v kombinaciji z drugimi imunosupresivi, poročali o kongenitalnih malformacijah; glejte poglavje 4.6.
Congenital malformations reported in infants born after a frozen-thawed embryo transfer (FTET) cycle
Prirojene malformacije, o katerih so poročali pri otrocih, rojenih po ciklu FTET
Congenital malformations, including reports of multiple malformations, have been observed post- marketing in children of patients exposed to CellCept during pregnancy in combination with other immunosuppressants.
Pri otrocih bolnic, ki so se v času nosečnosti zdravile z zdravilom CellCept v kombinaciji z drugimi imunosupresivi, so po prihodu zdravila na trg poročali o kongenitalnih malformacijah, vključno z večkratnimi malformacijami.
Congenital malformations, including reports of multiple malformations, have been observed post- marketing in children of patients exposed to CellCept during pregnancy in combination with other immunosuppressants. .
Pri otrocih bolnic, ki so se v času nosečnosti zdravile z zdravilom CellCept v kombinaciji z drugimi imunosupresivi, so po prihodu zdravila na trg poročali o kongenitalnih malformacijah, vključno z večkratnimi malformacijami.
Congenital malformations, including reports of multiple malformations, have been observed post- marketing in children of patients exposed to CellCept in combination with other immunosuppressants during pregnancy.
Pri otrocih bolnic, ki so se v času nosečnosti zdravile z zdravilom CellCept v kombinaciji z drugimi imunosupresivi, so po prihodu zdravila na trg poročali o kongenitalnih malformacijah, vključno z večkratnimi malformacijami.
Congenital malformations, including reports of multiple malformations, have been observed post- marketing in children of patients exposed to mycophenolate in combination with other immunosuppressants during pregnancy.
Pri otrocih bolnic, ki so se v času nosečnosti zdravile z mofetilmikofenolatom v kombinaciji z drugimi imunosupresivi, so po prihodu zdravila na trg poročali o kongenitalnih malformacijah, vključno z večkratnimi malformacijami.
Congenital malformations, including reports of multiple malformations, have been observed post- marketing in children of patients exposed to mycophenolate in combination with other immunosuppressants during pregnancy.
Pri otrocih bolnic, ki so se v času nosečnosti zdravile z mofetilmikofenolatom v kombinaciji z drugimi imunosupresivi, so po prihodu zdravila na trg poročali o kongenitalnih malformacijah,vključno z večkratnimi malformacijami.
Congenital malformations, including reports of multiple malformations, have been observed post- marketing in children of patients exposed to mycophenolate mofetil during pregnancy in combination with other immunosuppressants.
Pri otrocih bolnic, ki so se v času nosečnosti zdravile z zdravilom Myclausen v kombinaciji z drugimi imunosupresivi, so po prihodu zdravila na trg poročali o kongenitalnih malformacijah, vključno z večkratnimi malformacijami.
Congenital neutropenia
Kongenitalna nevtropenija
Congenital neutropenia:
Prirojena nevtropenija:
Congenital neutropenia: the recommended starting dose is 1.2 MU (12 micrograms)/kg/day as a single dose or in divided doses.
Prirojena nevtropenija: priporočeni začetni odmerek je 1,2 M e. (12 mikrogramov)/kg/dan v obliki enkratnega odmerka ali deljenih odmerkov.
congenital or acquired bleeding disorders
prirojene ali pridobljene motnje strjevanja krvi,
Congenital or acquired coagulation disorders
prirojene ali pridobljene motnje strjevanja krvi
Congenital or acquired QTc -prolongation.
prirojeno ali pridobljeno podaljšanje intervala QTc
Congenital or acquired QTc-prolongation.
prirojeno ali pridobljeno podaljšanje intervala QTc,
Congenital or acquired valvular defects with clinically relevant myocardial function disorders not related to pulmonary hypertension.
Prirojena ali pridobljena okvara zaklopke s klinično pomembno disfunkcijo miokarda, nepovezana s pljučno hipertenzijo.
congenital or documented acquired QT prolongation
prirojenim ali dokumentirano pridobljenim podaljšanjem intervala QT,
Congenital, and familial and genetic disorders
Vrojene, dedne in genetske okvare
Congenital, familial and genetic disorders
Prirojene, dedne in genetske okvare
Congenital, familial, and genetic disorder
Prirojene in dedne
Congenital, familial, and genetic disorder
Prirojene in dedne genetske okvare
Congenital, idiopathic or cyclic neutropenia ; filgrastim should be given by subcutaneous injection.
Prirojena, idiopatska ali ciklična nevtropenija: filgrastim se daje s subkutano injekcijo.
Congenital, idiopathic or cyclic neutropenia: Filgrastim should be given by subcutaneous injection.
Prirojena, idiopatska ali ciklična nevtropenija: Filgrastim se daje kot subkutana injekcija.
congestion
epistaksa, zamašenost sinusov
Congestion
kongestija,
congestion
zamašenost nosu
congestion in the nose, sinuses or upper part of the airway bringing air into the lungs
neprehodnost nosu, sinusov ali zgornjega dela dihalnih poti, ki vodijo v pljuča
Congestive cardiac failure
kongestivno popuščanje srca
Congestive heart failure
Zastojno srčno popuščanje
Congestive heart failure (CHF)
Kongestivno srčno popuščanje
Congestive heart failure (CHF)
Kongestivno srčno popuščanje (CHF)
Congestive heart failure (CHF): Dose titration in patients with moderate to severe CHF (NYHA Class III–IV) should be exercised with caution (see sections 4.4 and 5.2).
Kongestivno srčno popuščanje (Congestive Heart Failure - CHF): Pri titriranju odmerka za bolnike z zmernim do hudim CHF (III.–IV. razreda po razvrstitvi NYHA) je potrebna previdnost (glejte poglavji 4.4 in 5.2).
Congestive heart failure (NYHA Class II – IV) is a common adverse reaction associated with the use of Herceptin and has been associated with a fatal outcome (see section 4.4).
Kongestivno srčno popuščanje, NYHA razred II–IV, je pogost neželeni učinek, povezan z uporabo zdravila Herceptin; povezan je bil tudi s smrtnim izidom (glejte poglavje 4.4).
Congestive heart failure (NYHA Class II-IV) is a common adverse reaction to Herceptin.
Kongestivno srčno popuščanje (NYHA razred II–IV) je pogost neželeni učinek zdravila Herceptin.
Congestive heart failure (NYHA II-IV).
za bolnike s kongestivnim srčnim popuščanjem (NYHA II-IV),
Congestive heart failure (see below)
Zastojno srčno popuščanje (glejte spodaj)
Congestive heart failure (see section 4.4)
kongestivno srčno popuščanje (glejte poglavje 4.4)
Congestive heart failure due to cardiomyopathy may occur suddenly, and may also be encountered after discontinuation of therapy.
Do kongestivnega srčnega popuščanja kot posledice kardiomiopatije lahko pride nenadoma in tudi po prekinitvi zdravljenja.